Investigational Site Number :3760008

Jerusalem 91120

0 studies enrolling now · 3 studies all time

What they study most

Heart Failure, Non-relapsing Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Type 2 Diabetes Mellitus

Studies at this site

• Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS) — Completed
• Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) — Completed
• Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial) — Stopped early